| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP1140038B1 Transdermal drug delivery system |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
| 01/19/2005 | CN1566108A Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565623A Calcitonin composition |
| 01/19/2005 | CN1185251C Novel LHRH-antagonists with improved solubility characteristics |
| 01/19/2005 | CN1185249C Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185214C Novel indeno indolone compound, its preparation method and drug composition comprising the same |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | US6844445 Central nervous system disorders; psychological disorders |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844322 Administering a milk-secretion stimulating amount of: i)an estrogen-like agent; ii) a progestational agent; and iii) a somatotropin; may include adjusting the photo-period to which the animal is exposed |
| 01/13/2005 | WO2005002612A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | WO2005002603A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 01/13/2005 | WO2005002602A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | WO2005002600A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/13/2005 | US20050009907 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009801 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |
| 01/13/2005 | US20050009800 Solid, free-flowing dry extract of a natural mixture of conjugated equine estrogens that has been applied by spraying an aqueous solution of the mixture onto a powdered or granular microcrystalline cellulose support that may contain lactose |
| 01/13/2005 | US20050009799 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/13/2005 | US20050009798 Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
| 01/13/2005 | US20050009797 Androstane derivative having substituent in 7- abd 17--positions |
| 01/13/2005 | US20050008694 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | DE10328597A1 Arzneimittel, insbesondere zur Behandlung von Diabetes mellitus Typ 2 Medicines, particularly for the treatment of type 2 diabetes mellitus |
| 01/13/2005 | DE10327518A1 Synthetische Peptidkombinationen und Verfahren zu deren Herstellung Synthetic peptide combinations and methods for their preparation |
| 01/13/2005 | CA2531081A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | CA2530794A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 01/13/2005 | CA2530480A1 Conjugated complement cascade inhibitors |
| 01/12/2005 | EP1495768A1 Preventives/remedies for hotflash |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494630A2 Bioadhesive drug delivery system |
| 01/12/2005 | EP1355906B1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1286666B1 Starter kit for low dose oral contraceptives |
| 01/12/2005 | EP1153039B1 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1562262A Chinese herbal medicine for curing hyperthyroidism |
| 01/12/2005 | CN1562004A Preparation containing methimazole and its preparing method |
| 01/12/2005 | CN1184234C Preparation of stable zinc insulin analog crystals |
| 01/11/2005 | US6841617 Thermogelling biodegradable aqueous polymer solution |
| 01/11/2005 | US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/11/2005 | US6841548 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 01/06/2005 | WO2005000883A1 Polypeptides having binding affinity for insulin |
| 01/06/2005 | WO2005000846A1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 01/06/2005 | WO2005000795A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
| 01/06/2005 | WO2005000781A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | WO2005000775A2 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/06/2005 | WO2005000325A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004127 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004088 Hormonal contraceptive product |
| 01/06/2005 | US20050004076 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | CA2531058A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | CA2527659A1 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
| 01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1492508A1 Controlled release dosage forms |
| 01/05/2005 | EP1492501A1 Methods of using lamellar bodies for therapeutic purposes |
| 01/05/2005 | EP1227814B1 Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof |
| 01/05/2005 | EP0881891B1 Male contraceptive implant |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561219A Pharmaceutical compounds |
| 01/05/2005 | CN1561217A Estrogen/gestagen combination preparation and application thereof |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559396A Somatostat in prepn. for injection use, and its prepn. method |